Phase 4 EIN Clinical Trials
31 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 31 trials
Recruiting
Phase 4
Mechanochemical Ablation Versus Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein
Varicose Veins of Lower LimbVaricose Veins of Leg With Long Saphenous Vein Distribution
Antonio Eduardo Zerati50 enrolled1 locationNCT07561320
Recruiting
Phase 4
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
Venous ThromboembolismVaricose Veins
Imperial College London6,660 enrolled1 locationNCT05735639
Recruiting
Phase 4
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
CirrhosisAscitesPortal Vein Thrombosis+3 more
Asian Institute Of Medical Sciences220 enrolled1 locationNCT07521332
Recruiting
Phase 4
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Kidney TransplantFocal Segmental GlomerulosclerosisProteinuria+1 more
Travere Therapeutics, Inc.20 enrolled9 locationsNCT07219121
Recruiting
Phase 4
Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment
Retinal Vein Occlusion (RVO)
First Affiliated Hospital of Chongqing Medical University120 enrolled1 locationNCT07133438
Recruiting
Phase 4
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Henoch Schönlein Purpura Nephritis
Capital Institute of Pediatrics, China116 enrolled1 locationNCT07315191
Recruiting
Phase 4
Investigation of Locus Coeruleus Function in Sustained Attention
Attention - no Condition is Being Assessed - Healthy Adults
University of California, Davis40 enrolled1 locationNCT06041048
Recruiting
Phase 4
Nefecon and Ambrisentan in IgA Nephropathy
Chronic Kidney DiseaseIgA NephropathyProteinuria
The First Hospital of Jilin University129 enrolled1 locationNCT07030894
Recruiting
Phase 4
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+1 more
Leiden University Medical Center10,078 enrolled10 locationsNCT06581965
Recruiting
Phase 4
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
CirrhosisHCC - Hepatocellular CarcinomaPortal Vein Thrombosis
Mansoura University100 enrolled1 locationNCT07132515
Recruiting
Phase 4
Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
CancerVenous ThromboembolismUpper Extremity Deep Vein Thrombosis+1 more
Ottawa Hospital Research Institute330 enrolled1 locationNCT06603870
Recruiting
Phase 4
The Caffeine Therapy in the Fetal to Neonatal Transition
Mechanical Ventilation ComplicationVentilator Lung; NewbornCaffeine
Hospital de Clinicas de Porto Alegre50 enrolled1 locationNCT05454332
Recruiting
Phase 4
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
HypertensionMTHFR 677 CC or CT GenotypeElevated Plasma Homocysteine (Hcy≥10µmol/L)+1 more
Shenzhen Ausa Pharmed Co.,Ltd32,000 enrolled20 locationsNCT04974138
Recruiting
Phase 4
Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
Liver CancerSurgeryThrombosis, Deep Vein+2 more
Helsinki University Central Hospital1,012 enrolled7 locationsNCT04731558
Recruiting
Phase 4
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
HealthyCaffeineAdenosine+1 more
Hsiao-Ying Wey12 enrolled1 locationNCT06763172
Recruiting
Phase 4
Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft
Epstein-Barr Virus Infections
University Hospital, Strasbourg, France120 enrolled1 locationNCT04989491
Recruiting
Phase 4
Study of Foam Sclerotherapy Versus Ambulatory Phlebectomy
Varicose Veins
Imperial College London160 enrolled1 locationNCT03416413
Recruiting
Phase 4
Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis
N-AcetylcysteineTuberculosis (TB)Isoniazid Toxicity+6 more
Mahidol University116 enrolled1 locationNCT06484530
Recruiting
Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
SurgeryDeep Vein Thrombosis (DVT)Trauma+1 more
Oregon Health and Science University606 enrolled1 locationNCT02342444
Recruiting
Phase 4
Intravitreal Aflibercept for the Treatment of Treatment Resistant Macular Oedema secondary to Retinal Vein Occlusions
macular oedema secondary to retinal vein occlusion
A/Prof Andrew Chang50 enrolled1 locationACTRN12617001487303